-
Je něco špatně v tomto záznamu ?
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus
K. Schmiegelow, A. Attarbaschi, S. Barzilai, G. Escherich, TL. Frandsen, C. Halsey, R. Hough, S. Jeha, M. Kato, DC. Liang, TS. Mikkelsen, A. Möricke, R. Niinimäki, C. Piette, MC. Putti, E. Raetz, LB. Silverman, R. Skinner, R. Tuckuviene, I. van...
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
NLK
ProQuest Central
od 2000-09-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest)
od 2000-09-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2000-09-01 do Před 2 měsíci
Public Health Database (ProQuest)
od 2000-09-01 do Před 2 měsíci
- MeSH
- akutní lymfatická leukemie terapie MeSH
- delfská metoda MeSH
- dítě MeSH
- kombinovaná terapie škodlivé účinky MeSH
- konsensus MeSH
- lidé MeSH
- nežádoucí účinky léčiv etiologie prevence a kontrola MeSH
- testy akutní toxicity MeSH
- tolerance záření * MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Although there are high survival rates for children with acute lymphoblastic leukaemia, their outcome is often counterbalanced by the burden of toxic effects. This is because reported frequencies vary widely across studies, partly because of diverse definitions of toxic effects. Using the Delphi method, 15 international childhood acute lymphoblastic leukaemia study groups assessed acute lymphoblastic leukaemia protocols to address toxic effects that were to be considered by the Ponte di Legno working group. 14 acute toxic effects (hypersensitivity to asparaginase, hyperlipidaemia, osteonecrosis, asparaginase-associated pancreatitis, arterial hypertension, posterior reversible encephalopathy syndrome, seizures, depressed level of consciousness, methotrexate-related stroke-like syndrome, peripheral neuropathy, high-dose methotrexate-related nephrotoxicity, sinusoidal obstructive syndrome, thromboembolism, and Pneumocystis jirovecii pneumonia) that are serious but too rare to be addressed comprehensively within any single group, or are deemed to need consensus definitions for reliable incidence comparisons, were selected for assessment. Our results showed that none of the protocols addressed all 14 toxic effects, that no two protocols shared identical definitions of all toxic effects, and that no toxic effect definition was shared by all protocols. Using the Delphi method over three face-to-face plenary meetings, consensus definitions were obtained for all 14 toxic effects. In the overall assessment of outcome of acute lymphoblastic leukaemia treatment, these expert opinion-based definitions will allow reliable comparisons of frequencies and severities of acute toxic effects across treatment protocols, and facilitate international research on cause, guidelines for treatment adaptation, preventive strategies, and development of consensus algorithms for reporting on acute lymphoblastic leukaemia treatment.
Children's Cancer Center National Center for Child Health and Development Tokyo Japan
Clinic of Pediatric Hematology Oncology Department of Women's and Children's Health Padova Italy
Dana Farber Cancer Institute and Boston Children's Hospital Boston MA USA
Department of Pediatric and Adolescent Medicine Medical University of Vienna Vienna Austria
Department of Pediatric Hematology and Oncology St Anna Children's Hospital Vienna Austria
Department of Pediatric Oncology Langone Medical Center New York University New York NY USA
Department of Pediatrics Aalborg University Hospital Aalborg Denmark
Department of Pediatrics Aarhus University Hospital Aarhus N Denmark
Department of Pediatrics and Adolescent Medicine Rigshospitalet Copenhagen Denmark
Department of Pediatrics Oulu University Hospital Oulu Finland
Division of Pediatric Hematology Oncology Mackay Memorial Hospital Taipei Taiwan
Dutch Childhood Oncology Group The Hague Netherlands
Institute of Clinical Medicine Faculty of Medicine University of Copenhagen Copenhagen Denmark
St Jude Children's Research Hospital Memphis TN USA
University College London's NHS Foundation Trust London UK
University Hospital Motol Department of Pediatric Hematology Oncology Prague Czech Republic
University Medical Center Eppendorf Clinic of Pediatric Hematology and Oncology Hamburg Germany
University of Utah Department of Pediatrics and Huntsman Cancer Institute Salt Lake City UT USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023908
- 003
- CZ-PrNML
- 005
- 20170720123611.0
- 007
- ta
- 008
- 170720s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S1470-2045(16)30035-3 $2 doi
- 035 __
- $a (PubMed)27299279
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Schmiegelow, Kjeld $u Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark; Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Pediatric Oncology, Langone Medical Center, New York University, New York, NY, USA. Electronic address: kschmiegelow@rh.dk.
- 245 10
- $a Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus / $c K. Schmiegelow, A. Attarbaschi, S. Barzilai, G. Escherich, TL. Frandsen, C. Halsey, R. Hough, S. Jeha, M. Kato, DC. Liang, TS. Mikkelsen, A. Möricke, R. Niinimäki, C. Piette, MC. Putti, E. Raetz, LB. Silverman, R. Skinner, R. Tuckuviene, I. van der Sluis, E. Zapotocka, . ,
- 520 9_
- $a Although there are high survival rates for children with acute lymphoblastic leukaemia, their outcome is often counterbalanced by the burden of toxic effects. This is because reported frequencies vary widely across studies, partly because of diverse definitions of toxic effects. Using the Delphi method, 15 international childhood acute lymphoblastic leukaemia study groups assessed acute lymphoblastic leukaemia protocols to address toxic effects that were to be considered by the Ponte di Legno working group. 14 acute toxic effects (hypersensitivity to asparaginase, hyperlipidaemia, osteonecrosis, asparaginase-associated pancreatitis, arterial hypertension, posterior reversible encephalopathy syndrome, seizures, depressed level of consciousness, methotrexate-related stroke-like syndrome, peripheral neuropathy, high-dose methotrexate-related nephrotoxicity, sinusoidal obstructive syndrome, thromboembolism, and Pneumocystis jirovecii pneumonia) that are serious but too rare to be addressed comprehensively within any single group, or are deemed to need consensus definitions for reliable incidence comparisons, were selected for assessment. Our results showed that none of the protocols addressed all 14 toxic effects, that no two protocols shared identical definitions of all toxic effects, and that no toxic effect definition was shared by all protocols. Using the Delphi method over three face-to-face plenary meetings, consensus definitions were obtained for all 14 toxic effects. In the overall assessment of outcome of acute lymphoblastic leukaemia treatment, these expert opinion-based definitions will allow reliable comparisons of frequencies and severities of acute toxic effects across treatment protocols, and facilitate international research on cause, guidelines for treatment adaptation, preventive strategies, and development of consensus algorithms for reporting on acute lymphoblastic leukaemia treatment.
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a kombinovaná terapie $x škodlivé účinky $7 D003131
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a delfská metoda $7 D003697
- 650 _2
- $a nežádoucí účinky léčiv $x etiologie $x prevence a kontrola $7 D064420
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a akutní lymfatická leukemie $x terapie $7 D054198
- 650 12
- $a tolerance záření $7 D011836
- 650 _2
- $a testy akutní toxicity $7 D023382
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Attarbaschi, Andishe $u Department of Pediatric Hematology and Oncology, St Anna Children's Hospital, Vienna, Austria; Department of Pediatric and Adolescent Medicine, Medical University of Vienna, Vienna, Austria. $7 gn_A_00009851
- 700 1_
- $a Barzilai, Shlomit $u Schneider Children's Medical Center of Israel, Department of Pediatric Hematology Oncology, Petah-Tikva, Israel.
- 700 1_
- $a Escherich, Gabriele $u University Medical Center Eppendorf, Clinic of Pediatric Hematology and Oncology, Hamburg, Germany.
- 700 1_
- $a Frandsen, Thomas Leth $u Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.
- 700 1_
- $a Halsey, Christina $u Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
- 700 1_
- $a Hough, Rachael $u University College London's NHS Foundation Trust, London, UK.
- 700 1_
- $a Jeha, Sima $u St Jude Children's Research Hospital, Memphis, TN, USA.
- 700 1_
- $a Kato, Motohiro $u Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
- 700 1_
- $a Liang, Der-Cherng $u Division of Pediatric Hematology-Oncology, Mackay Memorial Hospital, Taipei, Taiwan.
- 700 1_
- $a Mikkelsen, Torben Stamm $u Department of Pediatrics, Aarhus University Hospital, Aarhus N, Denmark.
- 700 1_
- $a Möricke, Anja $u Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Department of Pediatrics, Kiel, Germany.
- 700 1_
- $a Niinimäki, Riitta $u Department of Pediatrics, Oulu University Hospital, Oulu, Finland.
- 700 1_
- $a Piette, Caroline $u EORTC Children's Leukemia Group and University Department of Pediatric Oncology CHR Citadelle, Liège, Belgium.
- 700 1_
- $a Putti, Maria Caterina $u Clinic of Pediatric Hematology Oncology, Department of Women's and Children's Health, Padova, Italy.
- 700 1_
- $a Raetz, Elizabeth $u University of Utah, Department of Pediatrics and Huntsman Cancer Institute, Salt Lake City, UT, USA.
- 700 1_
- $a Silverman, Lewis B $u Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.
- 700 1_
- $a Skinner, Roderick $u Department of Paediatric and Adolescent Haematology/Oncology, and Children's Haemopoietic Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle upon Tyne, UK.
- 700 1_
- $a Tuckuviene, Ruta $u Department of Pediatrics, Aalborg University Hospital, Aalborg, Denmark.
- 700 1_
- $a van der Sluis, Inge $u Dutch Childhood Oncology Group, The Hague, Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Department of Pediatric Hematology-Oncology, Rotterdam, Netherlands.
- 700 1_
- $a Zapotocka, Ester $u University Hospital Motol, Department of Pediatric Hematology/Oncology, Prague, Czech Republic.
- 700 1_
- $a ,
- 773 0_
- $w MED00011558 $t The Lancet. Oncology $x 1474-5488 $g Roč. 17, č. 6 (2016), s. e231-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27299279 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170720124103 $b ABA008
- 999 __
- $a ok $b bmc $g 1239589 $s 984821
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 17 $c 6 $d e231-9 $i 1474-5488 $m Lancet oncology $n Lancet Oncol. $x MED00011558
- LZP __
- $a Pubmed-20170720
